Position in AMGN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$500,087
+$55,701 QoQ
Shares Held
1,381
+9.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,183
of 3,140 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NIXON PEABODY TRUST CO holds $47,887,604 across 9 Drug Manufacturers - General names. AMGN ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,298 | $19,548,311 | |
| 2 | MRK |
Merck & Co., Inc.
|
77,974 | $10,019,659 | |
| 3 | AZN |
Astrazeneca PLC
|
42,186 | $7,999,309 | |
| 4 | JNJ |
Johnson & Johnson
|
22,335 | $5,672,419 | |
| 5 | ABBV |
AbbVie Inc.
|
8,249 | $2,075,778 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
11,564 | $1,460,995 | |
| 7 | AMGN |
Amgen Inc
This page
|
1,381 | $500,087 | |
| 8 | NVS |
Novartis AG
|
2,136 | $334,753 |
All Filings in AMGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $500,087 | 1,381 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $444,386 | 1,263 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $416,665 | 1,273 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $363,191 | 1,287 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $359,343 | 1,287 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $436,170 | 1,400 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $305,470 | 1,172 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $338,320 | 1,050 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $406,185 | 1,300 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $426,480 | 1,500 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $447,007 | 1,552 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||